CASR and neuroblastoma: When the same neuroblastoma cell lines were allowed to proliferate in the presence of concentrations lower than IC50 for 5 days, a moderate dose- and time-dependent decrease of cell viability was detected in CaSR-positive cells (Supplementary Figure S3B).